Lenvatinib Mesylate and Mumps virus vaccine, live Subcutaneous
Determining the interaction of Lenvatinib Mesylate and Mumps virus vaccine, live Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: Lenvatinib
Generic Name: mumps virus vaccine
Brand name:
Synonyms: Mumps virus vaccine, live (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lenvatinib Mesylate-Mumpsvax
- Lenvatinib Mesylate-Muromonab-cd3 Intravenous
- Lenvatinib Mesylate-Muse
- Lenvatinib Mesylate-Muse Micro Urethral
- Lenvatinib Mesylate-Muse Urethral
- Lenvatinib Mesylate-Mustargen
- Mumps virus vaccine, live Subcutaneous-Lenvima
- Mumps virus vaccine, live Subcutaneous-Lenvima (14 MG Daily Dose)
- Mumps virus vaccine, live Subcutaneous-Lenvima (18 MG Daily Dose)
- Mumps virus vaccine, live Subcutaneous-Lenvima (20 MG Daily Dose)
- Mumps virus vaccine, live Subcutaneous-Lenvima (24 MG Daily Dose)
- Mumps virus vaccine, live Subcutaneous-Lenvima (8 MG Daily Dose)